Viewing Study NCT01160666


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-03-04 @ 9:55 PM
Study NCT ID: NCT01160666
Status: COMPLETED
Last Update Posted: 2012-07-03
First Post: 2010-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sjögren's Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Belimumab View
None Sjögren's syndrome View
None Sjögren disease View